camptothecin has been researched along with v158411 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, L; Bedford, S; Browne, H; Christie, M; Drysdale, MJ; Fallowfield, M; Fiumana, A; Foloppe, N; Massey, AJ; Scrace, S; Stokes, S; Webb, P; Wood, M | 1 |
1 other study(ies) available for camptothecin and v158411
Article | Year |
---|---|
Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug design.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Cell Cycle; Cell Line, Tumor; Checkpoint Kinase 1; Colonic Neoplasms; Drug Design; Drug Synergism; Female; Humans; Indoles; Irinotecan; Mice; Mice, Nude; Protein Kinase Inhibitors; Protein Kinases; Pyridones; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2015 |